Increasing number of investments, launches, and collaborations is playing a vital role in the development of advanced diagnostic kits. For instance, in February 2020, Covaris, Inc. announced the release of two new kits for viral RNA extraction from nasal or throat swab sample collection devices. The first is the truXTRAC Viral RNA Extraction kit using Puritan Swabs, which contains all components for AFA-enhanced extraction and magnetic bead-based purification of high-quality RNA from synthetic swabs for downstream analysis. The healthcare professionals are also accepting the potential of swab collection kits in at-home settings during the unprecedented times of the COVID-19 pandemic, which represents the superiority of this necessity and technology over other techniques for reducing the risk of transmitting the virus. During the COVID-19 pandemic, numerous swab samples were taken for SARS-CoV-2 reverse transcriptase-polymerase chain reaction (RT-PCR) testing.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC swabs collection kit market at a good CAGR during the forecast period.
APAC swabs collection kit Market Segmentation
The APAC swabs collection kit market is analyzed on the basis of type, application, and country. Based on type, the market is segmented into nasopharyngeal swabs, oropharyngeal swabs, and others. The nasopharyngeal swabs dominated the market in 2020. Based on application, the market is segmented into microbiology laboratories, diagnostic laboratories, hospitals and clinics, home tests, and others. The hospitals and clinics segment dominated the market in 2020.
Based on country, the APAC swabs collection kit market is segmented into China, Japan, India, Australia, South Korea, and the Rest of APAC. India dominated the APAC swabs collection kit market in 2020.
BD; Puritan Medical Products Company LLC; Laboratory Corporation of America Holdings; HiMedia Laboratories; THERMO FISHER SCIENTIFIC INC.; Hardy Diagnostics; VIRCELL SL; BTNX, Inc; Formlabs; Lucence Diagnostics; Quidel Corporation; DiaSorin S.P.A; Copan Italia SPA; Norgen Biotek Corp; Hologic, Inc; Quest Diagnostics Incorporated; Abbott; Lynn Peavey Company; and QIAGEN by Altair are the leading companies in the APAC swabs collection kit market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 982.61 Million |
| Market Size by 2028 | US$ 1,373.90 Million |
| CAGR (2021 - 2028) | 4.9% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia-Pacific Swabs collection kit Market is valued at US$ 982.61 Million in 2021, it is projected to reach US$ 1,373.90 Million by 2028.
As per our report Asia-Pacific Swabs collection kit Market, the market size is valued at US$ 982.61 Million in 2021, projecting it to reach US$ 1,373.90 Million by 2028. This translates to a CAGR of approximately 4.9% during the forecast period.
The Asia-Pacific Swabs collection kit Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia-Pacific Swabs collection kit Market report:
The Asia-Pacific Swabs collection kit Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia-Pacific Swabs collection kit Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia-Pacific Swabs collection kit Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)